NHS National Pharmaceuticals Dasatinib and Paliperidone Injection
Proposed framework agreement for NHS National Generic Pharmaceuticals Dasatinib and Paliperidone Injection. Offer reference number: CM/PHG/22/5694<br/><br/><br/>Potential periods of call-offs under the framework agreement:<br/>CM/PHG/22/5694/00 - Dasatinib <br/>CESW 01/05/2023 – 30/04/2024 – (12 Months) <br/>LSNE 01/05/2023 – 30/04/2024 – (12 Months)<br/>NWLN 01/05/2023 – 30/04/2024 – (12 Months)<br/><br/>CM/PHG/22/5694/01 - Paliperidone Injection: <br/>LSNE 01/05/2023 – 31/05/2024 (13 Months) <br/>NWLN 01/05/2023...
Buyer
NHS England
Value
£108,792,862
Published
27 Apr 2023
Closes
21 Feb 2023
Procurement details
Source
Find a Tender
Region
United Kingdom
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 2 5. Lot 2 CM/PHG/22/5694/01 Supplier offer confirmation (check box)
£44,234,260
Invitation to offer for NHS National Generic Pharmaceuticals - Dasatinib and Paliperidone Injection<br/><br/>Period of framework agreement: The total maximum duration of the framework agreement to be no more than 21 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months.<br/>Potential per...
Delivery: United Kingdom
Lot 1 4. Lot 1 CM/PHG/22/5694/00 Supplier offer confirmation (check box)
£16,139,651
Invitation to offer for NHS National Generic Pharmaceuticals - Dasatinib and Paliperidone Injection<br/><br/>Period of framework agreement: The total maximum duration of the framework agreement to be no more than 21 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months. <br/>Potential pe...
Delivery: United Kingdom
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.